MEGALIA 40 mg /Ml Suspension

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

Doctor
0.0(0)

Sviatoslav Chekhun

OncologyGeneral medicine13 years of experience

Dr. Sviatoslav Chekhun is a medical oncologist with international clinical and research experience, specializing in modern medical oncology and a personalized approach to cancer treatment.

Currently (since 2025), he works as a Medical Oncologist at Institut Català d’Oncologia (Girona, Spain). Previously, he completed his residency in Medical Oncology and was involved in clinical research at Hospital Universitari Germans Trias i Pujol.

Dr. Chekhun has a strong academic and scientific background. He served as a lecturer in Internal Medicine at O.O. Bohomolets National Medical University and conducted research in experimental oncology at the R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology.

Earlier in his career, he worked as a medical oncologist at the Kyiv City Clinical Oncological Center and contributed to regulatory evaluation of medicinal products at the State Expert Center of the Ministry of Health of Ukraine.

When to consult Dr. Chekhun:

  •  for diagnosis or clarification of a cancer diagnosis
  •  to obtain a second opinion on an existing treatment plan 
  •  when you need a personalized treatment strategy 
  •  for interpretation of test results, CT, MRI, PET-CT, and biopsies 
  •  when choosing between treatment options (chemotherapy, targeted therapy, immunotherapy) 
  •  in case of doubts about treatment strategy or disease progression 

Consultation format

Dr. Chekhun provides online consultations, where you can receive:

  •  expert second opinion 
  •  detailed case review 
  •  recommendations based on current international treatment guidelines 
  •  personalized treatment and follow-up plan 

Important:
Prescription and monitoring of medications must be carried out by your treating physician in an in-person (offline) setting. An online consultation does not replace a face-to-face visit but helps you make more informed decisions about your treatment.

Dr. Sviatoslav Chekhun combines clinical practice, research, and international experience, enabling him to provide patients with modern, evidence-based approaches in oncology.

Book a video appointment
€286
This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use Megalia

Contents of the leaflet

  1. Package Leaflet: Information for the Patient
  2. MEGALIA, 40 mg/ml, Oral Suspension
    1. Read the package leaflet carefully before taking the medicine, as it contains important information for the patient.
    2. Table of Contents of the Leaflet:
  3. What is Megalia and what is it used for
  4. Important information before taking Megalia
  5. How to take Megalia
  6. Possible side effects
  7. How to store Megalia
  8. Contents of the pack and other information
  9. WHAT IS MEGALIA AND WHAT IS IT USED FOR
  10. IMPORTANT INFORMATION BEFORE TAKING MEGALIA
    1. When not to take Megalia
    2. Warnings and precautions
    3. Use in patients with renal and/or hepatic impairment
    4. Use in the elderly
    5. Children and adolescents
    6. Megalia and other medicines
    7. Pregnancy, breastfeeding, and fertility
    8. Driving and using machines
  11. HOW TO TAKE MEGALIA
    1. Method of administration
    2. Elderly patients
    3. Use in children and adolescents
    4. How long to take Megalia
    5. Taking more Megalia than prescribed
    6. Missing a dose of Megalia
  12. POSSIBLE SIDE EFFECTS
    1. If any of the side effects get serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.
    2. Reporting side effects
  13. HOW TO STORE MEGALIA
  14. CONTENTS OF THE PACK AND OTHER INFORMATION
    1. What Megalia contains
    2. What Megalia looks like and contents of the pack
    3. Marketing authorization holder and manufacturer
    4. Date of last revision of the leaflet:

Package Leaflet: Information for the Patient

MEGALIA, 40 mg/ml, Oral Suspension

Megestrol Acetate

Read the package leaflet carefully before taking the medicine, as it contains important information for the patient.

Keep this leaflet, you may need to read it again.
In case of any doubts, consult a doctor or pharmacist.
This medicine has been prescribed to you by a doctor. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours.
If you experience any side effects, including those not listed in this leaflet, tell your doctor or pharmacist. See section 4.

Table of Contents of the Leaflet:

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

1. What is Megalia and what is it used for

2. Important information before taking Megalia

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

3. How to take Megalia

4. Possible side effects

5. How to store Megalia

6. Contents of the pack and other information

1. WHAT IS MEGALIA AND WHAT IS IT USED FOR

The active substance of Megalia is megestrol acetate, a synthetic progestagen.
Megalia is indicated for the treatment of loss of appetite (anorexia) or weight loss due to cancer or acquired immunodeficiency syndrome (AIDS). The medicine is administered in the form of an oral suspension.

2. IMPORTANT INFORMATION BEFORE TAKING MEGALIA

Follow all the doctor's instructions.

When not to take Megalia

if you are allergic to megestrol acetate or any of the other ingredients of the medicine (listed in section 6),
if you are pregnant or breastfeeding.

Warnings and precautions

Before starting treatment with Megalia, discuss it with your doctor, pharmacist, or nurse.
Be particularly careful when taking Megalia
in patients who have had thrombophlebitis in the past,
in patients with diabetes - may increase insulin requirements.
Clinical and laboratory signs of mild adrenal suppression have been reported during and after treatment with megestrol acetate. In case of sudden discontinuation of the medicine, the patient should be closely monitored, especially for symptoms such as hypotension, nausea, vomiting, dizziness, or weakness.

Use in patients with renal and/or hepatic impairment

Before taking Megalia, inform your doctor if you have any liver or kidney problems.

Use in the elderly

Megalia can be used in the elderly.

Children and adolescents

The efficacy and safety of Megalia in children and adolescents have not been established.

Megalia and other medicines

Tell your doctor about all the medicines you are taking or have recently taken, as well as any medicines you plan to take.
No confirmed interactions between megestrol acetate and other concomitantly used medicines are known.

Pregnancy, breastfeeding, and fertility

Before taking any medicine, consult a doctor.
The medicine is contraindicated during pregnancy and breastfeeding.
In case of pregnancy or suspected pregnancy, inform your doctor.
In case of breastfeeding, consult a doctor.

Driving and using machines

There are no data on the effect of megestrol acetate on the ability to drive and use machines.
Megalia contains liquid maltitol(sweetener). If you have previously been diagnosed with intolerance to some sugars, consult your doctor before taking the medicine.

3. HOW TO TAKE MEGALIA

Always take Megalia exactly as your doctor has told you. If you are not sure, ask your doctor or pharmacist.

Method of administration

Before administration, shake the suspension well.
The usual dose is:
Adults:400 - 800 mg, (10 to 20 ml) orally.
Treatment with Megalia should be continued for at least two months.

Elderly patients

There is not enough data from clinical studies of megestrol acetate in patients aged 65 and over to determine whether they respond differently to the medicine than younger patients. Based on clinical experience, no differences in the effect of the medicine have been observed between elderly and younger patients. The dose should be chosen carefully in the elderly. Due to more frequent liver, kidney, or heart function disorders, as well as concomitant diseases and the use of other medicines, treatment usually starts with doses from the lower end of the dose range.
Megestrol acetate is mainly excreted by the kidneys. Therefore, the risk of toxic effects of the medicine may be higher in patients with impaired renal function. Since the occurrence of impaired renal function is more likely in the elderly, caution should be exercised when determining the dose, and monitoring of renal function may be useful.

Use in children and adolescents

Megalia is not recommended for use in children.

How long to take Megalia

Treatment with Megalia should be continued for at least two months.

Taking more Megalia than prescribed

Studies of the effects of taking high doses of the medicine (1,600 mg per day for 6 months) did not show any severe side effects.
In case of overdose, symptomatic treatment should be used.

Missing a dose of Megalia

Do not take a double dose to make up for a missed dose.
In case of any further doubts about taking the medicine, consult a doctor.
or pharmacist.

4. POSSIBLE SIDE EFFECTS

Like all medicines, Megalia can cause side effects, although not everybody gets them.
Common side effects(occurring in 1 to 10 patients out of 100):
nausea, vomiting, diarrhea, bloating, rash;
vaginal bleeding;
impotence (reduced sexual potency, erectile dysfunction);
weakness, pain, swelling at the injection site.
Side effects with unknown frequency(which cannot be estimated from available data):
rapid tumor growth;
adrenal insufficiency (symptoms: increasing weakness, loss of appetite, weight loss, nausea, vomiting, irritability);
symptoms similar to Cushing's syndrome, Cushing's syndrome (symptoms: obesity, moon face, stretch marks, hypertension, rapid fatigue);
diabetes, impaired glucose tolerance, hyperglycemia (high blood sugar levels, symptoms: excessive thirst, dry mouth, weight loss, drowsiness), increased appetite;
mood changes;
carpal tunnel syndrome (symptoms: tingling in the wrist and fingers, weakness of grip, lack of precision of movements), lethargy;
circulatory failure;
thrombophlebitis, pulmonary embolism (in some cases fatal), hypertension, hot flashes;
shortness of breath;
constipation;
hair loss;
frequent urination;
weight gain.
The main side effects observed in patients treated with megestrol acetate, especially in high doses, are weight gain, which is not usually associated with water retention in the body, but is the result of increased appetite and consumption of larger amounts of food.
This effect is the basis for the use of megestrol acetate in patients with anorexia or weight loss.

If any of the side effects get serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.

Reporting side effects

If you experience any side effects, including those not listed in the leaflet, tell your doctor or pharmacist. Side effects can be reported to the Department of Monitoring of Adverse Reactions to Medicinal Products of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products {current address, phone and fax number of the Department} e-mail: [email protected]
By reporting side effects, you can help provide more information on the safety of the medicine.

5. HOW TO STORE MEGALIA

Keep the medicine out of the sight and reach of children.
Do not use after the expiry date stated on the packaging. The first two digits indicate the month, and the last four digits indicate the year. The expiry date refers to the last day of the given month.
Store below 25°C.
Use within 24 days after opening.
Do not throw away medicines via wastewater or household waste. Ask your pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.

6. CONTENTS OF THE PACK AND OTHER INFORMATION

What Megalia contains

The active substance of Megalia is megestrol acetate.
It is available in the form of an oral suspension.
The other ingredients are: carbomer, macrogol glycerol hydroxystearate, sodium hydroxide (10%), citric acid monohydrate, sodium citrate, methyl p-hydroxybenzoate, propyl p-hydroxybenzoate, liquid maltitol, sodium saccharin, lemon flavor, purified water.

What Megalia looks like and contents of the pack

Megalia is available in polyethylene bottles with a screw cap and a measuring cup in a cardboard box. The bottle contains 240 ml of suspension.

Marketing authorization holder and manufacturer

Vipharm S.A.
ul. A. i F. Radziwiłłów 9
05-850 Ożarów Mazowiecki
tel.: +48 22 679 51 35
fax: +48 22 678 92 87
e-mail: [email protected]

Date of last revision of the leaflet:

  • Country of registration
  • Dosage form
    Suspension, 40 mg/ml
  • ATC code
    L02AB01
  • Active substance
  • Prescription required
    Yes
  • Manufacturer
  • Importer
    Vipharm S.A.
  • Alternatives to Megalia
    Dosage form: Suspension, 40 mg/ml
    Active substance: megestrol
    Manufacturer: Polfarmex S.A.
    Prescription required
    Dosage form: Suspension, 40 mg/ml
    Active substance: megestrol
    Prescription required
    Dosage form: Suspension, 40 mg/ml
    Active substance: megestrol

Online doctors for Megalia

Discuss questions about Megalia, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

Doctor
0.0(0)

Sviatoslav Chekhun

OncologyGeneral medicine13 years of experience

Dr. Sviatoslav Chekhun is a medical oncologist with international clinical and research experience, specializing in modern medical oncology and a personalized approach to cancer treatment.

Currently (since 2025), he works as a Medical Oncologist at Institut Català d’Oncologia (Girona, Spain). Previously, he completed his residency in Medical Oncology and was involved in clinical research at Hospital Universitari Germans Trias i Pujol.

Dr. Chekhun has a strong academic and scientific background. He served as a lecturer in Internal Medicine at O.O. Bohomolets National Medical University and conducted research in experimental oncology at the R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology.

Earlier in his career, he worked as a medical oncologist at the Kyiv City Clinical Oncological Center and contributed to regulatory evaluation of medicinal products at the State Expert Center of the Ministry of Health of Ukraine.

When to consult Dr. Chekhun:

  •  for diagnosis or clarification of a cancer diagnosis
  •  to obtain a second opinion on an existing treatment plan 
  •  when you need a personalized treatment strategy 
  •  for interpretation of test results, CT, MRI, PET-CT, and biopsies 
  •  when choosing between treatment options (chemotherapy, targeted therapy, immunotherapy) 
  •  in case of doubts about treatment strategy or disease progression 

Consultation format

Dr. Chekhun provides online consultations, where you can receive:

  •  expert second opinion 
  •  detailed case review 
  •  recommendations based on current international treatment guidelines 
  •  personalized treatment and follow-up plan 

Important:
Prescription and monitoring of medications must be carried out by your treating physician in an in-person (offline) setting. An online consultation does not replace a face-to-face visit but helps you make more informed decisions about your treatment.

Dr. Sviatoslav Chekhun combines clinical practice, research, and international experience, enabling him to provide patients with modern, evidence-based approaches in oncology.

Book a video appointment
€286

Get Megalia Prescription Online

1

Fill in a 2-min form

Tell us your symptoms, history, and what medicine you're requesting.

2

Pick a doctor or let us assign

Choose a specialist or we'll match you with the next available doctor.

3

Doctor reviews your case

Usually within 30 minutes. They may ask follow-up questions via chat.

4

Collect from any pharmacy

Electronic prescription sent to your email — valid across Spain.

Frequently Asked Questions

Is a prescription required for Megalia?

Megalia requires a prescription in Poland. You can check with a doctor online whether this medicine may be appropriate for your situation.

What is the active substance in Megalia?

The active ingredient in Megalia is megestrol. This information helps identify medicines with the same composition but different brand names.

Who manufactures Megalia?

Megalia is manufactured by Vipharm S.A.. Pharmacy brands and packaging may differ depending on the distributor.

Which doctors can assess the use of Megalia online?

Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether Megalia is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.

How to buy Megalia in Spain?

Spain has a well-developed healthcare infrastructure across major cities such as Madrid, Barcelona, Valencia, and Seville. Pharmacies are widely available and operate under strict regulations, ensuring access to prescribed medications.

You can buy Megalia in Madrid, Barcelona, Seville, or Valencia at any local pharmacy with a valid prescription.

To obtain a prescription, you can use Oladoctor:

What are the alternatives to Megalia?

Other medicines with the same active substance (megestrol) include Cahexan, Megace, Megastril. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media